Anyone know exits for biotech ER?? I am a newbie so forgive my naiveness.
My understanding is name brand MM HF’s don’t cover the biotech sector given the volatility around stock prices and their risk parameters.
Obviously, there are SM funds that cover biotech, but from this forum everyone keeps saying ER has a hard time placing into SM funds.
What does this leave??? SS ER forever?
Note I don’t have an MD/PhD and non target
| +81 | Q&A - Buyside Equity Research Analyst/PM | 29 | 1w | |
| +32 | How the heck do you learn all of this stuff? | 10 | 2d | |
| +28 | My experience on the sell side | 20 | 2w | |
| +24 | Clues in Financial Reporting Analysis | 7 | 3d | |
| +17 | Am i fairly compensated? | 9 | 5d | |
| +14 | Data Science to PM | 8 | 1w | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 2w | |
| +12 | ER - Remote Jobs? | 8 | 1w | |
| Equity Research at Bank vs IG, High Yield & Leveraged Loans Research at Asset Manager | 4 | 2d | ||
| +11 | Who uses sell-side Strategists? Are they valuable? | 4 | 1w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
Bump
Est odio ipsum ipsa incidunt placeat. Neque rerum aut est veniam qui voluptatem magnam. Perspiciatis omnis similique modi ipsa. Et dolor illum omnis quis excepturi cum aut asperiores.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...